Screener
Vertex Pharmaceuticals VRTX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's asset turnover?
- Vertex Pharmaceuticals (VRTX) reported asset turnover of 0.5× in Q2 2026.
- How has Vertex Pharmaceuticals's asset turnover changed year-over-year?
- Vertex Pharmaceuticals's asset turnover decreased by 5.4% year-over-year, from 0.5× to 0.5×.
- What is the long-term trend for Vertex Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's asset turnover has grown at a -4.2% compound annual growth rate (CAGR), from 0.6× to 0.5×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Vertex Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude